Exploring the Interplay: Obesity, Lipid Metabolism, and Clinical Manifestations in Atopic Dermatitis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The interest toward the association between atopic dermatitis (AD) and obesity is increasing, yet the possibility of abnormal lipid metabolism has never been investigated before. Objective: To identif y the characteristics of patients with AD who are obese and analyze the serum lipid profiles of these patients. Methods: This obser vational study included 167 patients diagnosed with AD and under went evaluations for serum lipid panels between July 2017 and October 2017. The patients’ body mass index was used to determine obesity and the serum lipid panels were analyzed between patients who are obese and non-obese. Also, the disease severity and subjective symptoms were evaluated and serum total immunoglobulin E (IgE) and specific IgE levels were assessed. Results: Of the 167 patients with AD, there were 36 obese and 131 non-obese subjects. Obese patients were found to have a significantly higher disease severity, as well as higher serum tri- glyceride and low-density lipoprotein-cholesterol levels and lower high-density lipoprotein-cho- lesterol levels, which was most pronounced in adult males. Obesity AD patients also had a significantly higher serum total IgE, itch intensity score, and number of allergens sensitized. Conclusion: Patients with AD who are obese should be monitored for possible abnormalities in lipid metabolism. Obesity may be a factor that contributes to a higher disease severity of AD.
Abstract
Background: The interest toward the association between atopic dermatitis (AD) and obesity is increasing, yet the possibility of abnormal lipid metabolism has never been investigated before. Objective: To identif y the characteristics of patients with AD who are obese and analyze the serum lipid profiles of these patients. Methods: This obser vational study included 167 patients diagnosed with AD and under went evaluations for serum lipid panels between July 2017 and October 2017. The patients’ body mass index was used to determine obesity and the serum lipid panels were analyzed between patients who are obese and non-obese. Also, the disease severity and subjective symptoms were evaluated and serum total immunoglobulin E (IgE) and specific IgE levels were assessed. Results: Of the 167 patients with AD, there were 36 obese and 131 non-obese subjects. Obese patients were found to have a significantly higher disease severity, as well as higher serum tri- glyceride and low-density lipoprotein-cholesterol levels and lower high-density lipoprotein-cho- lesterol levels, which was most pronounced in adult males. Obesity AD patients also had a significantly higher serum total IgE, itch intensity score, and number of allergens sensitized. Conclusion: Patients with AD who are obese should be monitored for possible abnormalities in lipid metabolism. Obesity may be a factor that contributes to a higher disease severity of AD.
참고문헌 (26)
- Nousbeck J, "Atopic dermatitis according to GARP : new mechanistic insights in disease pathogenesis", J Invest Dermatol, 136, pp.2340~2341 (2016)
- Silverberg JI, "Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults", Ann Allergy Asthma Immunol, 121, pp.604~612 (2018)
- Brunner PM, "Increasing comorbidities suggest that atopic dermatitis is a systemic disorder", J Invest Dermatol, 137, pp.18~25 (2017)
- Baumann S, "Obesity-a promoter of allergy?", Int Arch Allergy Immunol, 162, pp.205~213 (2013)
- Silverberg JI, "Association between atopic dermatitis and obesity in adulthood", Br J Dermatol, 166, pp.498~504 (2012)
- Silverberg JI, "Central obesity and high blood pressure in pediatric patients with atopic dermatitis", JAMA Dermatol, 151, pp.144~152 (2015)
- Boulet LP, "Obesity and atopy", Clin Exp Allergy, 45, pp.75~86 (2015)
- Silverberg JI, "Association between obesity and atopic dermatitis in childhood : a case-control study", J Allergy Clin Immunol, 127, pp.1180~1186 (2011)
- Ali Z, "Is atopic dermatitis associated with obesity? A systematic review of observational studies", J Eur Acad Dermatol Venereol, 32, pp.1246~1255 (2018)
- Jung MJ, "Effect of weight reduction on treatment outcomes for patients with atopic dermatitis", Ann Dermatol, 32, pp.319~326 (2020)
- Cottrell L, "Metabolic abnormalities in children with asthma", Am J Respir Crit Care Med, 183, pp.441~448 (2011)
- Chen YC, "Lipid profiles in children with and without asthma : interaction of asthma and obesity on hyperlipidemia", Diabetes Metab Syndr, 7, pp.20~25 (2013)
- World Health Organization Western Pacific Region, "The Asia-Pacific perspective: redefining obesity and its treatment" (2000), Health Communications Australia
- Hanifin JM, "The eczema area and severity index-a practical guide", Dermatitis, 33, pp.187~192 (2022)
- Darlenski R, "Atopic dermatitis as a systemic disease", Clin Dermatol, 32, pp.409~413 (2014)
- Zhang A, "Association of atopic dermatitis with being overweight and obese : a systematic review and metaanalysis", J Am Acad Dermatol, 72, pp.606~616 (2015)
- Koutroulis I, "Atopic dermatitis is more severe in children over the age of two who have an increased body mass index", Acta Paediatr, 104, pp.713~717 (2015)
- Wang Z, "Age variation in the association between obesity and mortality in adults", Obesity(Silver Spring), 25, pp.2137~2141 (2017)
- Fang LJ, "The lipid profile in obese asthmatic children compared to non-obese asthmatic children", Allergol Immunopathol(Madr), 44, pp.346~350 (2016)
- Barochia AV, "High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics", J Lipid Res, 58, pp.1713~1721 (2017)
- Thijs J, "Biomarkers for atopic dermatitis : a systematic review and meta-analysis", Curr Opin Allergy Clin Immunol, 15, pp.453~460 (2015)
- Kang K, "Adipocyte-derived Th2 cytokines and myeloid PPARδ regulate macrophage polarization and insulin sensitivity", Cell Metab, 7, pp.485~495 (2008)
- Brunner PM, "The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies", J Allergy Clin Immunol, 139, pp.S65~S76 (2017)
- Szczepankiewicz D, "Interleukin 4 affects lipid metabolism and the expression of pro-inflammatory factors in mature rat adipocytes", Immunobiology, 223, pp.677~683 (2018)
- Howell MD, "Cytokine modulation of atopic dermatitis filaggrin skin expression", J Allergy Clin Immunol, 124, pp.R7~R12 (2009)
- Hönzke S, "Influence of Th2 cytokines on the cornified envelope, tight junction proteins, and ß-defensins in filaggrin-deficient skin equivalents", J Invest Dermatol, 136, pp.631~639 (2016)